{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:19:37Z","timestamp":1767183577626,"version":"build-2065373602"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"am","delay-in-days":305,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015060","name":"Nagasaki University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18H02972","18J20543","19K22724","26290040","LS097"],"award-info":[{"award-number":["18H02972","18J20543","19K22724","26290040","LS097"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.gene.2022.146234","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T11:33:03Z","timestamp":1643628783000},"page":"146234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Oncogenic Runx1\u2013Myc axis in p53-deficient thymic lymphoma"],"prefix":"10.1016","volume":"819","author":[{"given":"Yuki","family":"Date","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Taniuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kosei","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.gene.2022.146234_b0005","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1074-7613(01)00088-7","article-title":"Analysis of C-MYC function in normal cells via conditional gene-targeted mutation","volume":"14","author":"de Alboran","year":"2001","journal-title":"Immunity"},{"issue":"12","key":"10.1016\/j.gene.2022.146234_b0010","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1158\/2159-8290.CD-19-0471","article-title":"GATA3-Controlled Nucleosome Eviction Drives MYC Enhancer Activity in T-cell Development and Leukemia","volume":"9","author":"Belver","year":"2019","journal-title":"Cancer Discovery"},{"issue":"1","key":"10.1016\/j.gene.2022.146234_b0015","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.bcmd.2009.01.013","article-title":"Runx1 promotes B-cell survival and lymphoma development","volume":"43","author":"Blyth","year":"2009","journal-title":"Blood Cells Mol. Dis."},{"issue":"3","key":"10.1016\/j.gene.2022.146234_b0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.onc.1204090","article-title":"Runx2: A novel oncogenic effector revealed by in vivo complementation and retroviral tagging","volume":"20","author":"Blyth","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2022.146234_b0025","first-page":"1717","article-title":"Synergy between a human c-myc transgene and p53 null genotype in murine thymic lymphomas: contrasting effects of homozygous and heterozygous p53 loss","volume":"10","author":"Blyth","year":"1995","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.gene.2022.146234_b0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","article-title":"Targeting transcription factors in cancer - from undruggable to reality","volume":"19","author":"Bushweller","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.gene.2022.146234_b0035","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1182\/blood-2017-03-775536","article-title":"RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia","volume":"130","author":"Choi","year":"2017","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.gene.2022.146234_b0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nri2489","article-title":"RUNX proteins in transcription factor networks that regulate T-cell lineage choice","volume":"9","author":"Collins","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.gene.2022.146234_b0045","doi-asserted-by":"crossref","first-page":"14592","DOI":"10.1073\/pnas.1200037109","article-title":"Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1-CBF\u03b2 interaction","volume":"109","author":"Cunningham","year":"2012","journal-title":"PNAS"},{"issue":"11","key":"10.1016\/j.gene.2022.146234_b0050","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nrc2731","article-title":"20 years studying p53 functions in genetically engineered mice","volume":"9","author":"Donehower","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.gene.2022.146234_b0055","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1182\/blood-2006-02-005900","article-title":"c-Myc mediates pre-TCR-induced proliferation but not developmental progression","volume":"108","author":"Dose","year":"2006","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.gene.2022.146234_b0060","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","article-title":"Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis","volume":"13","author":"Eischen","year":"1999","journal-title":"Genes Dev."},{"issue":"49","key":"10.1016\/j.gene.2022.146234_b0065","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1038\/onc.2009.290","article-title":"Transcription activity is required for p53-dependent tumor suppression","volume":"28","author":"Gaidarenko","year":"2009","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.gene.2022.146234_b0070","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1038\/leu.2016.106","article-title":"\u03b2-Catenin is required for T-cell leukemia initiation and MYC transcription downstream of Notch1","volume":"30","author":"Gekas","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.gene.2022.146234_b0075","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/gcc.22039","article-title":"The molecular profile of adult T-cell acute lymphoblastic leukemia: Mutations in RUNX1 and DNMT3A are associated with poor prognosis in T-ALL","volume":"52","author":"Grossmann","year":"2013","journal-title":"Genes Chromosomes Cancer"},{"issue":"10","key":"10.1016\/j.gene.2022.146234_b0080","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/nm.3665","article-title":"A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia","volume":"20","author":"Herranz","year":"2014","journal-title":"Nat. Med."},{"issue":"17","key":"10.1016\/j.gene.2022.146234_b0085","doi-asserted-by":"crossref","first-page":"7423","DOI":"10.1128\/MCB.25.17.7423-7431.2005","article-title":"p53-Dependent transcriptional repression of c-myc is required for G1 cell cycle arrest","volume":"25","author":"Ho","year":"2005","journal-title":"Mol. Cell. Biol."},{"issue":"2","key":"10.1016\/j.gene.2022.146234_b0090","doi-asserted-by":"crossref","first-page":"e1004167","DOI":"10.1371\/journal.pgen.1004167","article-title":"Insertional mutagenesis and deep profiling reveals gene hierarchies and a Myc\/p53-dependent bottleneck in lymphomagenesis","volume":"10","author":"Huser","year":"2014","journal-title":"PLoS Genet."},{"key":"10.1016\/j.gene.2022.146234_b0095","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ebiom.2016.04.032","article-title":"Small Molecule Inhibitor of CBF\u03b2-RUNX Binding for RUNX Transcription Factor Driven Cancers","volume":"8","author":"Illendula","year":"2016","journal-title":"EBioMedicine"},{"issue":"2","key":"10.1016\/j.gene.2022.146234_b0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/nrc3877","article-title":"The RUNX family: developmental regulators in cancer","volume":"15","author":"Ito","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"7","key":"10.1016\/j.gene.2022.146234_b0105","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/jbmr.2814","article-title":"Cbfb2 Isoform Dominates More Potent Cbfb1 and Is Required for Skeletal Development","volume":"31","author":"Jiang","year":"2016","journal-title":"J. Bone Miner. Res."},{"issue":"4","key":"10.1016\/j.gene.2022.146234_b0110","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ng747","article-title":"Synergistic tumor suppressor activity of BRCA2 and p53 in a conditional mouse model for breast cancer","volume":"29","author":"Jonkers","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2022.146234_b0115","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1093\/emboj\/18.6.1609","article-title":"Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains","volume":"18","author":"Kim","year":"1999","journal-title":"Embo J."},{"key":"10.1016\/j.gene.2022.146234_b0120","doi-asserted-by":"crossref","first-page":"701924","DOI":"10.3389\/fimmu.2021.701924","article-title":"Runx Transcription Factors in T Cells\u2014What Is Beyond Thymic Development?","volume":"12","author":"Korinfskaya","year":"2021","journal-title":"Front. Immunol."},{"issue":"12","key":"10.1016\/j.gene.2022.146234_b0125","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.trecan.2018.10.003","article-title":"The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer","volume":"4","author":"Lancho","year":"2018","journal-title":"Trends Cancer"},{"issue":"48","key":"10.1016\/j.gene.2022.146234_b0130","doi-asserted-by":"crossref","first-page":"19685","DOI":"10.1073\/pnas.1206406109","article-title":"A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis","volume":"109","author":"Link","year":"2012","journal-title":"Proc. National Acad. Sci."},{"issue":"8","key":"10.1016\/j.gene.2022.146234_b0135","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/ng.3909","article-title":"The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia","volume":"49","author":"Liu","year":"2017","journal-title":"Nat. Genet."},{"issue":"7","key":"10.1016\/j.gene.2022.146234_b0140","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.cell.2006.12.007","article-title":"Modeling the Therapeutic Efficacy of p53 Restoration in Tumors","volume":"127","author":"Martins","year":"2006","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.gene.2022.146234_b0145","doi-asserted-by":"crossref","DOI":"10.1172\/JCI141566","article-title":"RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia","volume":"131","author":"Matthijssens","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"9822","key":"10.1016\/j.gene.2022.146234_b0150","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0140-6736(11)61177-X","article-title":"Burkitt\u2019s lymphoma","volume":"379","author":"Molyneux","year":"2012","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.gene.2022.146234_b0155","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1172\/JCI91788","article-title":"Genetic regulation of the RUNX transcription factor family has antitumor effects","volume":"127","author":"Morita","year":"2017","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.gene.2022.146234_b0160","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1084\/jem.20062456","article-title":"Repression of interleukin-4 in T helper type 1 cells by Runx\/Cbf\u03b2 binding to the Il4 silencer","volume":"204","author":"Naoe","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.gene.2022.146234_b0165","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-981-10-3233-2_16","article-title":"The RUNX Genes as Conditional Oncogenes: Insights from Retroviral Targeting and Mouse Models","volume":"962","author":"Neil","year":"2017","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.gene.2022.146234_b0170","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1002\/stem.507","article-title":"A Runx1 intronic enhancer marks hemogenic endothelial cells and hematopoietic stem cells","volume":"28","author":"Ng","year":"2010","journal-title":"Stem Cells (Dayton, Ohio)"},{"key":"10.1016\/j.gene.2022.146234_b0175","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1182\/blood-2007-07-100883","article-title":"Runx1-mediated hematopoietic stem-cell emergence is controlled by a Gata\/Ets\/SCL-regulated enhancer","volume":"110","author":"Nottingham","year":"2007","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.gene.2022.146234_b0180","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.molcel.2019.12.014","article-title":"p53 Activates the Long Noncoding RNA Pvt1b to Inhibit Myc and Suppress Tumorigenesis","volume":"77","author":"Olivero","year":"2020","journal-title":"Mol. Cell"},{"issue":"5","key":"10.1016\/j.gene.2022.146234_b0185","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41388-021-02120-w","article-title":"Runx3 is required for oncogenic Myc upregulation in p53-deficient osteosarcoma","volume":"41","author":"Otani","year":"2022","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.gene.2022.146234_b0190","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.molcel.2017.07.028","article-title":"Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response","volume":"67","author":"Porter","year":"2017","journal-title":"Mol. Cell"},{"issue":"1","key":"10.1016\/j.gene.2022.146234_b0195","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cell.2018.05.048","article-title":"CBF\u03b2-SMMHC Inhibition Triggers Apoptosis by Disrupting MYC Chromatin Dynamics in Acute Myeloid Leukemia","volume":"174","author":"Pulikkan","year":"2018","journal-title":"Cell"},{"issue":"11","key":"10.1016\/j.gene.2022.146234_b0200","doi-asserted-by":"crossref","first-page":"e1009169","DOI":"10.1371\/journal.pgen.1009169","article-title":"Runx2 is essential for the transdifferentiation of chondrocytes into osteoblasts","volume":"16","author":"Qin","year":"2020","journal-title":"Plos Genet"},{"issue":"15","key":"10.1016\/j.gene.2022.146234_b0205","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1038\/sj.onc.1203508","article-title":"Reversible activation of c-Myc in thymocytes enhances positive selection and induces proliferation and apoptosis in vitro","volume":"19","author":"Rudolph","year":"2000","journal-title":"Oncogene"},{"issue":"9","key":"10.1016\/j.gene.2022.146234_b0210","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1073\/pnas.0808042106","article-title":"p53 represses c-Myc through induction of the tumor suppressor miR-145","volume":"106","author":"Sachdeva","year":"2009","journal-title":"PNAS"},{"issue":"20","key":"10.1016\/j.gene.2022.146234_b0215","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1101\/gad.13.20.2670","article-title":"INK4a\/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53","volume":"13","author":"Schmitt","year":"1999","journal-title":"Genes Dev."},{"issue":"10","key":"10.1016\/j.gene.2022.146234_b0220","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1038\/leu.2017.40","article-title":"RUNX3 is oncogenic in natural killer\/T-cell lymphoma and is transcriptionally regulated by MYC","volume":"31","author":"Selvarajan","year":"2017","journal-title":"Leukemia"},{"issue":"11","key":"10.1016\/j.gene.2022.146234_b0225","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/35099076","article-title":"The ETS-domain transcription factor family","volume":"2","author":"Sharrocks","year":"2001","journal-title":"Nat. Rev. Mol. Cell Bio"},{"issue":"24","key":"10.1016\/j.gene.2022.146234_b0230","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1101\/gad.232710.113","article-title":"Role of SWI\/SNF in acute leukemia maintenance and enhancer-mediated Myc regulation","volume":"27","author":"Shi","year":"2013","journal-title":"Genes Dev."},{"issue":"8","key":"10.1016\/j.gene.2022.146234_b0235","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/cas.12199","article-title":"Roles of AML1\/RUNX1 in T-cell malignancy induced by loss of p53","volume":"104","author":"Shimizu","year":"2013","journal-title":"Cancer Sci."},{"key":"10.1016\/j.gene.2022.146234_b0240","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.gene.2022.146234_b0245","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1038\/sj.onc.1208404","article-title":"Transcriptional cross-regulation of RUNX1 by RUNX3 in human B cells","volume":"24","author":"Spender","year":"2005","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.gene.2022.146234_b0250","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0092-8674(02)01111-X","article-title":"Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development","volume":"111","author":"Taniuchi","year":"2002","journal-title":"Cell"},{"issue":"50","key":"10.1016\/j.gene.2022.146234_b0255","doi-asserted-by":"crossref","first-page":"7124","DOI":"10.1038\/sj.onc.1203202","article-title":"A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc","volume":"18","author":"Vaillant","year":"1999","journal-title":"Oncogene"},{"issue":"7128","key":"10.1016\/j.gene.2022.146234_b0260","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05541","article-title":"Restoration of p53 function leads to tumour regression in vivo","volume":"445","author":"Ventura","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.gene.2022.146234_b0265","doi-asserted-by":"crossref","first-page":"34742","DOI":"10.1074\/jbc.M602492200","article-title":"The Cell Cycle Inhibitor p21 waf1 Binds to the myc and cdc25A Promoters upon DNA Damage and Induces Transcriptional Repression*","volume":"281","author":"Vigneron","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.gene.2022.146234_b0270","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ccr.2011.03.010","article-title":"High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF\/\u03b2-catenin target gene, CDC25A","volume":"19","author":"Vijayakumar","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2022.146234_b0275","first-page":"7181","article-title":"Proviral insertion indicates a dominant oncogenic role for Runx1\/AML-1 in T-cell lymphoma","volume":"62","author":"Wotton","year":"2002","journal-title":"Cancer Res."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111922000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111922000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T16:48:15Z","timestamp":1759855695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111922000531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":55,"alternative-id":["S0378111922000531"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2022.146234","relation":{},"ISSN":["0378-1119"],"issn-type":[{"type":"print","value":"0378-1119"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncogenic Runx1\u2013Myc axis in p53-deficient thymic lymphoma","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2022.146234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"146234"}}